Jones Financial Companies
RVPH

Jones Financial Companies’s REVIVA PHARMA HLDGS INC RVPH Stock Holding History

Jones Financial Companies’s Portfolio RVPH Stock Details RVPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-42
Closed -$283 – 4354
2025
Q2 		$283 Hold
42
– – ﹤0.01% 3877
2025
Q1 		$848 Hold
42
– – ﹤0.01% 3432
2024
Q4 		$1.52K Buy
+42
New +$1.17K ﹤0.01% 3064

Other funds holding RVPH

DP
Diadema Partners Morristown, New Jersey $588M AUM 182.75% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PAP
Persistent Asset Partners Hong Kong $335M AUM 275.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return
ECM
EMC Capital Management Houston, Texas $253M AUM

Jones Financial Companies's RVPH Position: Q3 2025 in Review

Jones Financial Companies sold out of REVIVA PHARMA HLDGS INC (RVPH) in Q3 2025, closing a stake of 42 shares — an estimated $283 sold.

Jones Financial Companies first reported a position in RVPH in Q4 2024 and held it in 3 quarters. The position peaked at $1.52K in Q4 2024. 42 funds tracked by Wall St. Rank hold RVPH as of Q3 2025.

  • Jones Financial Companies reported no remaining REVIVA PHARMA HLDGS INC position as of Q3 2025 after selling out during the quarter.
  • Jones Financial Companies sold 42 REVIVA PHARMA HLDGS INC shares in Q3 2025, an estimated $283.
  • Jones Financial Companies first reported a position in REVIVA PHARMA HLDGS INC in Q4 2024 and held it in 3 quarters.
  • Jones Financial Companies's REVIVA PHARMA HLDGS INC position peaked at $1.52K in Q4 2024.
  • 42 funds tracked by Wall St. Rank held REVIVA PHARMA HLDGS INC as of Q3 2025.

Based on Jones Financial Companies's 13F filing for Q3 2025, filed 4 Nov 2025.